Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Patent
1995-02-08
1996-09-17
Draper, Garnette D.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
435 6952, 435 697, 530395, 530403, 536 234, A61K 3820, C07K 1455, C12N 1562
Patent
active
055569463
ABSTRACT:
Disclosed are (1) a fused protein obtained by combining an antigen used for vaccine and a lymphokine by the application of gene engineering, (2) a recombinant DNA containing a nucleotide sequence coding for the above fused protein, (3) a transformant bearing the above recombinant DNA, (4) a method for producing the fused protein which comprises cultivating the above transformant, producing and accumulating the above fused protein in a culture, and collecting the fused protein, and (5) a hybrid protein obtained by chemically combining an antigen used for vaccine with a lymphokine. The resulting fused and hybrid proteins have strong immunogenicity.
REFERENCES:
Weinberg et al., Journal of Immunology, 140:1, pp. 294-299 (1988).
R. Seno et al., FEBS, 199:2, pp. 187-192 (1986).
Aono Aki
Fujisawa Yukio
Hinuma Shuji
Buckley Linda M.
Conlin David G.
Draper Garnette D.
Takeda Chemical Industries Ltd.
Ulm John D.
LandOfFree
Interleukin-2/viral antigen protein chimers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin-2/viral antigen protein chimers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-2/viral antigen protein chimers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-413991